Prof. Schuster has received an NSF CAREER award, entitled “Surfactant Proteins that Stabilize Biomolecular Condensates: From Biophysics to Biomaterials for Biomanufacturing,” to support his lab’s research as well as associated educational/outreach efforts.
December 7, 2022
CBE Distinguished Professor Alex Neimark (PI) and Research Assistant Professor Kolattukudy Santo (Co-PI) have received an award from the Pittsburgh Supercomputing Center (PSC) to study adsorption of pulmonary surfactants on Spike proteins of Covid-19 coronavirus variants by microseconds long molecular dynamics (MD) simulations on Anton 2 special-purpose supercomputer. Anton 2 is the next- generation specialized supercomputer generously made available by D.E. Shaw Research and hosted by PSC through Grant R01GM116961 from the National Institutes of Health.
November 16, 2022
Prof. Mark Pierce (BME) and Prof. Prabhas Moghe were awarded a 1-year, $154,769 grant to advance a novel imaging contrast agent developed at Rutgers toward commercial adoption. The award, from the NIH’s C3i program, will allow the team to develop methods to synthesize infrared light-emitting nanocomposites at commercial scales. The nanocomposites can be used to highlight specific tissues within the body and are expected to find applications in preclinical imaging for drug discovery and in image-guided surgical resection of tumors.
July 25, 2022
Prof. Neimark has received a $50,000 research award from Colgate-Palmolive titled "Coarse-grained Modeling of Surfactant and Amino Acid Adsorption on Dental Biofilms". The aim of this industrial project under the Master Services Agreement between Colgate-Palmolive Company and Rutgers is to explore using mesoscale simulations the mechanisms of surfactant and amino acid adsorption on dental biofilms. The success of this project may inform the experimentalists in their search for health care formulations with improved properties. The period of the project is for 1 year.
June 1, 2022
Dr. Shapley receives a $5,000 Core Facility Utilization grant toward her work on MRI imaging of nonuniform particle distributions in highly filled, non-Newtonian liquids.
May 12, 2022
Prof. Dutt has received a $382,260 research award from the National Science Foundation (NSF) REU program titled " Advanced Materials at Rutgers Engineering ".
April 27, 2022
Dr. Ramachandran receives a $5,000 Core Facility Utilization grant toward his group’s work on high-resolution imaging to further develop mechanistic models of high shear granulation processes.
April 20, 2022
Prof. Neimark has received a $40,000 Rutgers Busch Biomedical award titled " Molecular Design of Biomimetic Lipid Membranes and Liposome". The project aims at the development of the multiscale molecular simulation methods to study the physicochemical properties and stability of lipid membranes and their interactions with functional nanoparticles. The period of the project is for 2 years.
April 20, 2022
Prof. Neimark has received a $157,500 research award from Colgate-Palmolive titled " Computational Modeling of Xanthan Gum Solutions". The project aims at developing coarse-grained dissipative particle dynamics simulation methods to study the effects of metal-complexation on the morphological and rheological properties of polysaccharide solutions. As a case-study example, we consider Xanthan gum (XG) solutions containing ZnCl2 that are widely used in food and personal, and health care products.
April 20, 2022
Prof. Neimark has received a $55,000 research award from the NJ ACTS Pilot project grant program titled " Development of Computational Models to Explore Interactions of Coronavirus Virions with Lung Surfactant Films". Coronavirus (CoV) virions, such as SARS-CoV-2, are complex core-shell nanoparticles of spheroidal shape, bound by the lipid bilayer envelope of ~85 nm diameter decorated by a “crown” of 20 nm long Spike protein protrusions. The lung surfactant (LS) is the first line of defense in the lung against airborne nanoparticles, like CoV virions. LS affects the ability of CoV to penetrate and infect the respiratory system, and therefore, is a target of potential “surfactant” therapies to cure severe acute respiratory syndrome (SARS) caused by COVID-19.